-
Vollering wins Tour de France Femmes after war of nerves
-
BMW iX3 Flow Edition brings animated bodywork closer to reality
-
BMW’s next chapter accelerates with New Class rollout
-
Arteta backs Guimaraes to 'ignite something different' at Arsenal
-
Five dead in new Russia, Ukraine strikes
-
Como sign England defender Chalobah from Chelsea
-
PSG sign France full-back Digne from Villa
-
Demi Vollering wins Tour de France Femmes
-
Sinner withdraws from Cincinnati Open with knee injury
-
Iraola's first Anfield match as Liverpool manager ends in Monaco defeat
-
Fernandez's 'perfect' race earns him British MotoGP Grand Prix win
-
Bodies hanging from bridge revive violence in once-calm town in Mexico
-
Iran Guards say won't reopen Hormuz without US meeting Tehran's demands
-
Lionel Messi bids farewell to father who guided his glittering career
-
Hogh's hat-trick inspires Celtic to 5-1 victory over Kilmarnock
-
Raul Fernandez wins British MotoGP Grand Prix
-
London grants first licences for supervised Uber robotaxis
-
Tesla FSD secrecy puts Europe’s safety oversight under scrutiny
-
Erasmus hopeful Kolisi hamstring injury not 'too bad'
-
Mercedes-AMG GT 53 balances speed, range and daily usability
-
Luxury car buyers trade prestige for mainstream value
-
Lion queen Werro focused on Euro medal, not 800m world record
-
Students, teachers mourn girl killed in Thailand school shooting
-
Changan uses FILDA 2026 to accelerate its African expansion
-
Jacobson to lead New Zealand for first time against Sharks
-
Honda plots a profitable European comeback without a price war
-
Typhoon Dolphin makes landfall in China after flight cancellations, evacuations
-
Iran Guards say won't reopen Hormuz without US meeting all Tehran's conditions
-
South Korea FA apologises after sex scandal adds to controversies
-
Messi absent after father's death as Miami lose in Leagues Cup
-
Indonesia closes national park as wildfire spreads
-
Flight cancellations, evacuations in China as Typhoon Dolphin looms
-
ZXMoto leads China's charge to dominate the global motorbike market
-
Iran issues demands for reopening of Hormuz
-
Top-ranked Sabalenka, Pegula stunned in Toronto fourth round
-
Afghanistan's gold rush upends lives and landscapes
-
Japan nuclear debate unnerves proponents of pacifism
-
Messi missing after father's death as Miami lose in Leagues Cup
-
Spanish teen Jodar ousts eighth seed Lehecka at Montreal
-
World number one Sabalenka ousted in Toronto by Alexandrova
-
Angers mounts in US over vast network of car license plate cams
-
Olympic weightlifter hoists debris for Venezuela earthquake recovery
-
Darderi to face Nakashima in Montreal quarter-finals
-
FIFA condemns 'concerted and ongoing effort' to weaken Infantino
-
Espresso power fires Darderi past Borges in Montreal
-
South Africa win after surviving late Argentina surge
-
Shnaider upsets Pegula to book Toronto quarter-final with Swiatek
-
Man Utd boss Carrick being 'careful' with Mount as Man Utd draw with PSG
Ghostwriters, polo shirts, and the fall of a landmark pesticide study
A flagship study that declared the weedkiller Roundup posed no serious health risks has been retracted with little fanfare, ending a 25-year saga that exposed how corporate interests can distort scientific research and influence government decision-making.
Published in Regulatory Toxicology and Pharmacology in 2000, the paper ranks in the top 0.1 percent of citations among studies on glyphosate -- the key ingredient in Roundup, owned by agri-giant Monsanto and at the center of cancer lawsuits worth billions of dollars.
In his retraction note last week, the journal's editor-in-chief, Martin van den Berg, cited a litany of serious flaws from failing to include carcinogenicity studies available at the time to undisclosed contributions by Monsanto employees and even questions around financial compensation.
Elsevier, the journal's Dutch publisher, told AFP in a statement that it upholds the "highest standards of rigor and ethics" and that "as soon as the current editor became aware of concerns regarding this paper a matter of months ago, due process began."
But it did not address the fact that concerns date back to 2002, when critics wrote to Elsevier about "conflicts of interest, lack of transparency, and the absence of editorial independence" at the journal, including specific worries about Monsanto.
The matter exploded into public view in 2017, when internal corporate documents released during litigation showed one of Monsanto's own scientists admitting to "ghostwriting."
Harvard University science historian Naomi Oreskes, who co-authored a paper this September detailing the extent of the "fraud" in the 2000 study, told AFP that while she was "very gratified" at the "long overdue" action, but warned that "the scientific community needs better mechanisms to identify and retract fraudulent papers."
"This is completely in alignment with what we were calling them out for at the time," Lynn Goldman, a pediatrician and epidemiologist at GWU who co-signed the 2002 letter, added to AFP.
- Polo shirts -
Two of the paper's three original authors have since died, while first author Gary Williams, a professor at New York Medical College, did not respond to AFP's request for comment.
Monsanto maintains it acted appropriately, and that its product is safe. "Monsanto's involvement with the Williams et al paper did not rise to the level of authorship and was appropriately disclosed in the acknowledgments."
The company declined to comment on internal emails that suggested otherwise, including one in which a Monsanto scientist asked a colleague whether "the team of people" who worked on the Williams paper and another study "could receive Roundup polo shorts as a token of appreciation for a job well done."
Glyphosate was brought to market as a herbicide in the 1970s and initially welcomed as less toxic than DDT.
But its soaring use -- especially after Monsanto introduced glyphosate-tolerant seeds that allowed it to be sprayed widely over crops -- drew increasing scrutiny in the 1990s, making the 2000 paper hugely influential.
According to Oreskes's research, it was cited as supporting evidence for glyphosate's safety by groups ranging from the Canadian Forest Service to the International Court of Justice, the US Congress and the European Parliamentary Research Service.
- Legal interest -
In 2015, the World Health Organization's International Agency for Research on Cancer classified glyphosate as "probably carcinogenic to humans."
Several countries have since moved to restrict or ban its use, including France, which has prohibited household applications. Bayer, which acquired Monsanto, said it would phase out Roundup for US residential use in 2023 in response to growing lawsuits.
Nathan Donley, a scientist with the Center for Biological Diversity, told AFP he does not expect the retraction to sway the US Environmental Protection Agency, now under the pro-agricultural-industry Donald Trump administration, which has thrown its weight behind Bayer in an ongoing Supreme Court case.
But "it could play a role in litigation that is moving forward in the US against the EPA's proposed decision to renew glyphosate," Donley told AFP, adding that European regulators might also take note.
For Donley and others, the deeper concern is that the case may be far from unique.
"I am sure there (are a) lot (of) such ghost-written and undeclared conflict papers in the literature, but they are very difficult to unearth unless one goes really deep in litigation cases," John Ioannidis, a Stanford University professor who founded the field of meta-research told AFP.
D.Schneider--BTB